Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection

Clinica Chimica Acta

Volumn 373, Issue 1-2, 2006, Pages 172-175

  Shi, Ming ^a,b   Yang, Zhi Jun ^c   Wang, Rong Sheng ^d   Zhang, Hua ^d   Zhu, Yu Fen ^d   Xu, Yong Ping ^a   Lin, Qiu Ye ^a   Jin, Li Ji ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b Dalian Hospital of Infectious Diseases   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d Jiangsu Oil Field Hospital   (China)

Author keywords

Hepatitis B virus; Mutation; Real time PCR; YMDD

Indexed keywords

DNA; LAMIVUDINE;

ARTICLE; BLOOD SAMPLING; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURAL GENE; WILD TYPE;

CHILD, PRESCHOOL; CHINA; COST-BENEFIT ANALYSIS; DRUG RESISTANCE, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; LAMIVUDINE; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

HEPATITIS B VIRUS;

EID: 33748148287     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.05.023     Document Type: Article

References (11)

1. Leung N.W., Lai C.L., Chang T.T., Guan R., Lee C.M., Ng K.Y., et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 33 (2001) 1527-1532
2. Hu K.Q. A practical approach to management of chronic hepatitis B. Int J Med Sci 2 (2005) 17-23
3. Allen M.I., Deslauriers M., Andrews C., Tipples G.A., Walters K.A., Tyrrell D.L., et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine clinical investigation group. Hepatology 27 (1998) 1670-1677
4. Niesters H.G., De Man R.A., Pas S.D., Fries E., and Osterhaus A.D. Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy. J Med Microbiol 51 (2002) 695-699
5. Pillier C., Castera L., Soulier A., Hezode C., Nordmann P., Dhumeaux D., et al. Dynamics of hepatitis B virus resistance to lamivudine. J Virol 80 (2006) 643-653
6. Sablon E., and Shapiro F. Advances in molecular diagnosis of HBV infection and drug resistance. Int J Med Sci 2 (2005) 8-16
7. Wang R.S., Zhang H., Zhu Y.F., Han B., and Yang Z.J. Detection of YMDD mutants using universal template real-time PCR. World J Gastroenterol 12 (2006) 1308-1311
8. Cane P.A., Cook P., Ratcliffe D., Mutimer D., and Pillay D. Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus. Antimicrob Agents Chenother 43 (1999) 1600-1608
9. Punia P., Cane P., Teo C.G., and Saunders N. Quantitation of hepatitis B lamivudine resistant mutants by real-time amplification refractory mutation system PCR. J Hepatol 40 (2004) 986-992
10. Bernard P.S., and Wittwer C.T. Real-time PCR technology for cancer diagnostics. Clin Chem 48 (2002) 1178-1185
11. Kobayashi S., Ide T., and Sata M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J Hepatol 34 (2001) 584-586